Imaging DNA damage response by ?H2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome. (2023)

First Author: O'Neill E
Attributed to:  Imaging DNA damage repair during radionuclide therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/thno.82101

PubMed Identifier: 36923536

Publication URI: http://europepmc.org/abstract/MED/36923536

Type: Journal Article/Review

Volume: 13

Parent Publication: Theranostics

Issue: 4

ISSN: 1838-7640